 This is a phase I, single-blind, randomized, placebo-controlled single and repeated ascending dose study to assess the safety, tolerability and pharmacokinetics with oral doses of AZD1305 extended-release capsules in healthy male Japanese and Caucasian subjects. Three or four if needed dose levels will be given to Japanese subjects and one of the doses will also be given to Caucasian subjects. 